Literature DB >> 16529387

Metformin use during the first trimester of pregnancy. Is it safe?

Gideon Koren, Cameron Gilbert, Maria Valois.   

Abstract

QUESTION: A pregnant patient with polycystic ovary syndrome asked me whether continuing metformin, which she was taking to treat infertility before her pregnancy, is safe for her fetus. She has heard that metformin is a "drug for diabetes." How safe is it to take metformin during the first trimester of pregnancy and beyond? ANSWER: Despite the traditional response that all oral hypoglycemic agents are absolutely contraindicated during pregnancy, evidence that metformin is probably safe during the first trimester of pregnancy and beyond is accumulating. Results of a recent meta-analysis by the Motherisk Program showed no increase in incidence of major malformations and a potential protective effect in this patient population.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16529387      PMCID: PMC1479727     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  13 in total

1.  Effect of metformin on mouse embryo development.

Authors:  M A Bedaiwy; K F Miller; J M Goldberg; D Nelson; T Falcone
Journal:  Fertil Steril       Date:  2001-11       Impact factor: 7.329

Review 2.  Metformin for the treatment of polycystic ovary syndrome.

Authors:  Robert L Barbieri
Journal:  Obstet Gynecol       Date:  2003-04       Impact factor: 7.661

3.  Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first-trimester spontaneous abortion: a pilot study.

Authors:  C J Glueck; H Phillips; D Cameron; L Sieve-Smith; P Wang
Journal:  Fertil Steril       Date:  2001-01       Impact factor: 7.329

4.  Effects of in-utero exposure to oral hypoglycaemic drugs.

Authors:  K Piacquadio; D R Hollingsworth; H Murphy
Journal:  Lancet       Date:  1991-10-05       Impact factor: 79.321

Review 5.  Glyburide and fetal safety; transplacental pharmacokinetic considerations.

Authors:  G Koren
Journal:  Reprod Toxicol       Date:  2001 May-Jun       Impact factor: 3.143

6.  Oral hypoglycaemic agents in 118 diabetic pregnancies.

Authors:  E Hellmuth; P Damm; L Mølsted-Pedersen
Journal:  Diabet Med       Date:  2000-07       Impact factor: 4.359

7.  A comparison of glyburide and insulin in women with gestational diabetes mellitus.

Authors:  O Langer; D L Conway; M D Berkus; E M Xenakis; O Gonzales
Journal:  N Engl J Med       Date:  2000-10-19       Impact factor: 91.245

8.  Metformin therapy throughout pregnancy reduces the development of gestational diabetes in women with polycystic ovary syndrome.

Authors:  C J Glueck; Ping Wang; Suichi Kobayashi; Harvey Phillips; Luann Sieve-Smith
Journal:  Fertil Steril       Date:  2002-03       Impact factor: 7.329

Review 9.  Insulin resistance and metformin in polycystic ovary syndrome.

Authors:  Avi Ben-Haroush; Yariv Yogev; Benjamin Fisch
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2004-08-10       Impact factor: 2.435

Review 10.  Metformin in obstetric and gynecologic practice: a review.

Authors:  Elizabeth A McCarthy; Susan P Walker; Kylie McLachlan; Jacqui Boyle; Michael Permezel
Journal:  Obstet Gynecol Surv       Date:  2004-02       Impact factor: 2.347

View more
  1 in total

Review 1.  The Role of Metformin in Metabolic Disturbances during Pregnancy: Polycystic Ovary Syndrome and Gestational Diabetes Mellitus.

Authors:  Joselyn Rojas; Mervin Chávez-Castillo; Valmore Bermúdez
Journal:  Int J Reprod Med       Date:  2014-12-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.